Derek Thomas – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Derek Thomas on 2016-06-07.
To ask the Secretary of State for Health, what steps he is taking to improve GP access to natriuretic peptide testing.
Jane Ellison
NHS England is working with key partners to ensure better co-ordination and integration of all services with the aim of delivering person-centred and coordinated care which is tailored to the needs and preferences of the individual, their carer and family.
Specifically on heart failure, NHS England is working with Health Education England to look at ways of improving the provision of and increase access to echocardiography, which is used for the diagnosis of heart failure.
NHS England has also established a best practice tariff for acute heart failure. This aims to encourage better practice in the caring for heart failure patients. In addition, the National Institute for Health and Care Excellence (NICE) has published quality standards for acute heart failure and chronic heart failure, which can be found at:
https://www.nice.org.uk/Guidance/QS9
https://www.nice.org.uk/guidance/qs103
NHS England expects commissioners and providers to take account of quality standards in the services that are delivered to patients.
The use of natriuretic peptides in diagnosing heart failure is widely understood and pathology laboratories are used to measuring them. The NICE’s guidance on acute heart failure and chronic heart failure both cover the use of natriuretic peptides. This guidance can be found at:
https://www.nice.org.uk/guidance/cg108
https://www.nice.org.uk/guidance/cg187
The NICE has also developed a commissioning toolkit for the use of natriuretic peptides assessment in primary care for suspected heart failure:
“
